Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 394-399, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutton, J.
Right arrow Articles by Roberts, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dutton, J.
Right arrow Articles by Roberts, N. B.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 1999;45:394-399.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Evaluation of a New Method for the Analysis of Free Catecholamines in Plasma Using Automated Sample Trace Enrichment with Dialysis and HPLC

John Dutton1, Andrew J. Hodgkinson1, George Hutchinson2 and Norman B. Roberts1,a

1 Department of Clinical Chemistry, Royal Liverpool and Broadgreen University, Hospital NHS Trust, Liverpool L7, 8XP, United Kingdom.

2 Anachem Ltd, Luton LU2 0EB, United Kingdom.
a Author for correspondence. Fax 44 (1)51 706 5813.

Background: Analysis of urinary free catecholamines was automated recently, but analysis of plasma samples posed special difficulties. The present study was undertaken to evaluate a new method for the automated analysis of plasma catecholamines.

Methods: The procedure is based on an improved sample handling system that includes dialysis and sample clean-up on a strong cation trace-enrichment cartridge. The catecholamines norepinephrine, epinephrine, and dopamine are then separated by reversed-phase ion-pair chromatography and quantified by electrochemical detection.

Results: Use of a 740-µL sample is required to give the catecholamine detection limit of 0.05 nmol/L and analytical imprecision (CV) between 1.1% and 9.3%. The assay can be run unattended, although >12 h of analysis time is not recommended without cooling of the autosampler rack. Comparison (n = 68) of the automated cation-exchange clean-up with the well-established manual alumina procedure gave excellent agreement (mean, 3.78 ± 2.76 and 3.8 ± 2.89 nmol/L for norepinephrine and 0.99 ± 1.72 and 1.08 ± 1.78 nmol/L for epinephrine). Hemodialysis had no clear effect on plasma norepinephrine. Epinephrine concentrations were similar (0.05 < P < 0.1) in chronic renal failure patients (0.24 ± 0.3 nmol/L; n = 15) and healthy controls (0.5 ± 0.24 nmol/L; n = 31). Dopamine was not quantified, being usually <0.2 nmol/L.

Conclusion: The availability of such a fully automated procedure should encourage the more widespread use of plasma catecholamine estimation, e.g., after dialysis, exercise, or trauma/surgery and in the investigation of catecholamine-secreting tumors, particularly in the anuric patient. © 1999 American Association for Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
 Anesth. Analg.Home page
A. M. Mukhtar, E. M. Obayah, and A. M. Hassona
The use of dexmedetomidine in pediatric cardiac surgery.
Anesth. Analg., July 1, 2006; 103(1): 52 - 56.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.